secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001178913-25-002515
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics effects 1-for-15 reverse stock split, adjusts warrant terms
--------------------------------------------------------------------------------

- Reverse split effective after close July 28; trading on split-adjusted basis July 29 under same ticker SLXN.
- Authorized shares unchanged at 1,481,482; par value increased from $0.0009 to $0.0135 per share.
- Each warrant now exercisable for 1/15th of a share; exercise price adjusted to $1,552.50 per whole share.
- No fractional shares will be issued; fractional interests rounded up to nearest whole share.
- CUSIP for ordinary shares changed to G1281K 130; warrant CUSIP remains G1281K 114.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002515/0001178913-25-002515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325002515/zk2533495.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-002515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer